Drug General Information
Drug ID
D01ILH
Former ID
DNC002901
Drug Name
B-2-Octylglucoside
Drug Type
Small molecular drug
Indication Discovery agent Investigative [551393]
Structure
Download
2D MOL

3D MOL

Formula
C14H28O6
Canonical SMILES
CCCCCCCCOC1C(C(C(OC1O)CO)O)O
InChI
1S/C14H28O6/c1-2-3-4-5-6-7-8-19-13-12(17)11(16)10(9-15)20-14(13)18/h10-18H,2-9H2,1H3/t10-,11-,12+,13-,14-/m1/s1
InChIKey
BVHPDIWLWHHJPD-RKQHYHRCSA-N
PubChem Compound ID
PubChem Substance ID
Target and Pathway
Target(s) Cytochrome B Target Info Inhibitor [551393]
Rhodopsin Target Info Inhibitor [551393]
KEGG Pathway Oxidative phosphorylation
Metabolic pathwayshsa04744:Phototransduction
PANTHER Pathway Heterotrimeric G-protein signaling pathway-rod outer segment phototransduction
Pathway Interaction Database Visual signal transduction: Rods
Reactome The canonical retinoid cycle in rods (twilight vision)
Inactivation, recovery and regulation of the phototransduction cascade
G alpha (i) signalling events
WikiPathways GPCRs, Class A Rhodopsin-like
Visual phototransduction
Regulation of Microtubule Cytoskeleton
Integrated Breast Cancer Pathway
Integrin-mediated Cell Adhesion
References
Ref 551393How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6.
Ref 551393How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6.

If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.